GLP-1 and Menopause: Staying Organized Through the Transition

Menopause is the natural point when menstrual periods end, usually preceded by a transitional phase called perimenopause that can last several years. During this time, hormone levels shift, and many people notice changes in sleep, energy, mood, appetite, and how and where their body stores weight. In the long-running Study of Women's Health Across the Nation (SWAN), the pace of fat gain doubled and lean mass began to decline at the start of the transition, even though weight itself did not speed up (Greendale et al., JCI Insight, 7 March 2019). A smaller four-year study found that visceral (deep abdominal) fat rose, and sleeping energy expenditure fell further, in women who became postmenopausal (Lovejoy et al., International Journal of Obesity, June 2008).

Because these changes can arrive gradually, it is not always obvious what is driving what. Some people explore GLP-1 medications with their healthcare provider as one part of a broader weight-management plan during this stage of life. Whether that is appropriate depends on your full health history, and only a qualified clinician can make that call with you.

The goal of this page is simply to help you understand the landscape and come to appointments organized, with your own data in hand rather than relying on memory.

GLP-1 medications are prescription treatments that work with a hormone-related pathway involved in appetite and blood sugar regulation. Brand names people may track include Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, and Saxenda. Each is different, and they are not interchangeable; what is right for one person may not be right for another. None of the Wegovy, Zepbound, Ozempic, or Mounjaro labels lists menopause as an indication: Section 1 of the Wegovy and Zepbound prescribing information (via DailyMed, accessed 20 October 2026) covers weight management in people with obesity, or adults with overweight plus at least one weight-related condition, and the Ozempic and Mounjaro labels are for type 2 diabetes.

We do not recommend one medication over another, and we do not suggest starting, stopping, switching, or changing a dose. Those conversations belong with your prescriber, who can weigh your individual needs, other medications, and overall health.

If you are already taking a GLP-1 medication, the practical question often becomes how to stay consistent and notice patterns over time. That is where careful tracking can quietly make a difference.

During the menopause transition, it can be genuinely hard to tell whether something you feel is related to hormonal changes, a medication, daily life, or some mix of all three. Commonly reported GLP-1 side effects, described in general terms, include digestive changes such as nausea, and shifts in energy and appetite that can also overlap with how many people describe the menopause transition itself. This is not an exhaustive list, and everyone's experience is different.

Because of that overlap, a written record is useful. GLP-1 Tracker lets you log side effects and notes alongside your doses, meals, and weight, so you can see how things change week to week instead of guessing.

If anything feels concerning, severe, or persistent, contact your healthcare provider. A clear log of what you noticed and when can make that conversation faster and more accurate.

GLP-1 Tracker is designed to reduce the mental load of managing the day-to-day. You can record each dose, rotate and note injection sites, and view an educational "medication level" estimate that helps you visualize timing between doses. None of this replaces guidance from your clinician; it simply keeps your information tidy and in one place.

For meals, the AI photo scan estimates calories, protein, and fiber with a protein-first emphasis, which many people appreciate when appetite is changing. Alongside that, you can track weight, BMI, and progress photos to see your trends over time, and set reminders so consistency feels less like a chore.

When you head to an appointment, you can bring a clear, organized history instead of trying to recall it. Otis, our otter mascot, is along for the ride to keep the tone warm and encouraging rather than clinical.

The menopause transition is a time when many people pay closer attention to muscle and bone, since the hormonal changes of this stage can affect both. Strength, balance, and getting enough protein are themes that often come up in conversations with providers, especially for anyone focused on weight management. We are not giving medical or nutrition advice here, and your clinician is the right person to tailor any plan to you, but it can be a worthwhile topic to raise at your next visit.

This is one reason GLP-1 Tracker leans into protein-aware meal logging. When you snap a photo, the AI scan provides an estimate of calories, protein, and fiber, so you can follow your protein trend over days and weeks rather than guessing. These figures are approximate and meant for personal awareness, not clinical precision. Paired with weight, BMI, and progress photos, that record can help you and your provider talk about the whole picture, not just the number on the scale.

Weight is only one signal during the menopause transition, and on its own it can be a frustrating one. Sleep quality, energy levels, mood, hot flashes, appetite, and digestion all tend to move around during this stage, and they can color how a week feels even when the scale barely changes. Noticing these alongside your weight often tells a richer story.

In GLP-1 Tracker, your side-effect notes and reminders sit right next to your doses, meals, and weight, so you can jot down how a day actually went and look back later for patterns. Over time, this gives you context the scale cannot provide, plus a clearer, organized history to bring to appointments instead of relying on memory. It is a record to share with your provider, not a substitute for their guidance.